Caliway Biopharmaceuticals Co., Ltd. (TPEX: 6919)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
541.00
-14.00 (-2.52%)
Sep 10, 2024, 2:59 PM CST

Caliway Biopharmaceuticals Revenue

Caliway Biopharmaceuticals had revenue of 7.85M TWD in the quarter ending June 30, 2024, a decrease of -31.92%. This brings the company's revenue in the last twelve months to 35.52M, up 26.93% year-over-year. In the year 2023, Caliway Biopharmaceuticals had annual revenue of 38.93M with 203.68% growth.

Revenue (ttm)
35.52M
Revenue Growth
+26.93%
P/S Ratio
2,011.32
Revenue / Employee
n/a
Employees
n/a
Market Cap
75.43B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202338.93M26.11M203.68%
Dec 31, 202212.82M481.00K3.90%
Dec 31, 202112.34M1.99M19.22%
Dec 31, 202010.35M-8.30M-44.50%
Dec 31, 201918.65M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition